# Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treating Treatment of Type 2 Diabetes

> **NCT05925829** · PHASE1 · COMPLETED · sponsor: **Hayandra Peduli Foundation** · enrollment: 39 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Platelet-rich Plasma
- Stromal Vascular Fraction

## Interventions

- **BIOLOGICAL:** SVF and aaPRP

## Key facts

- **NCT ID:** NCT05925829
- **Lead sponsor:** Hayandra Peduli Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2017-12-01
- **Final completion:** 2017-12-01
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2023-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05925829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05925829, "Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treating Treatment of Type 2 Diabetes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05925829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*